Comparison of the effectiveness of surgical treatment of uterine fibroids (literature review)

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

In review describes the possibilities, advantages and disadvantages of various types of surgical treatment of uterine fibroids, based on the latest evidence-based medicine regarding their effectiveness and safety.

全文:

受限制的访问

作者简介

V. Kaptilnyy

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

编辑信件的主要联系方式.
Email: rtchilova@gmail.com
ORCID iD: 0000-0002-2656-132X

Associate Professor, Candidate of Medical Sciences

俄罗斯联邦

M. Poznyak

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0006-8217-0784
俄罗斯联邦

R. Chilova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0001-6331-3109

Professor, MD

俄罗斯联邦

D. Lystsev

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0006-3826-3174
俄罗斯联邦

E. Svidinskaya

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0002-2368-1932

Candidate of Medical Sciences

俄罗斯联邦

K. Budnikova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0003-3644-2292

Candidate of Medical Sciences

俄罗斯联邦

G. Proklova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0003-3382-026X

Candidate of Medical Sciences

俄罗斯联邦

T. Manucheva

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0003-8907-1090
俄罗斯联邦

Z. Kokhreidze

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0004-4339-2558
俄罗斯联邦

G. Sevastyanov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0000-4823-9510
俄罗斯联邦

参考

  1. Mas A., Tarazona M., Dasi Carrasco J. et al. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017; 9: 607–17. doi: 10.2147/IJWH.S138982
  2. Gurusamy K.S., Vaughan J., Fraser I.S. et al. Medical Therapies for Uterine Fibroids – A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. PLoS One. 2016; 11 (2): e0149631. doi: 10.1371/journal.pone.0149631
  3. Lee S.M., Choi E.S., Ha E. et al. Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) Ameliorates Human Uterine Myomas Via Apoptosis. Front Pharmacol. 2019; 10: 1105. doi: 10.3389/fphar.2019.01105
  4. Verpalen I.M., Anneveldt K.J., Nijholt I.M. et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis. Eur J Radiol. 2019; 120: 108700. doi: 10.1016/j.ejrad.2019.108700
  5. Liu L., Wang T., Lei B. High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis. Eur Radiol. 2022; 32 (2): 1195–204. doi: 10.1007/s00330-021-08156-6
  6. Liu L., Wang T., Lei B. Ultrasound-guided Microwave Ablation in the Management of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021; 28 (12): 1982–92. doi: 10.1016/j.jmig.2021.06.020
  7. Liu L., Wang T., Lei B. Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021; 28 (2): 218–27. doi: 10.1016/j.jmig.2020.11.004
  8. Li F., Chen J., Yin L. et al. HIFU as an alternative modality for patients with uterine fibroids who require fertility-sparing treatment. Int J Hyperthermia. 2023; 40 (1): 2155077. doi: 10.1080/02656736.2022.2155077
  9. Kohi M.P., Spies J.B. Updates on Uterine Artery Embolization. Semin Intervent Radiol. 2018; 35 (1): 48–55. doi: 10.1055/s-0038-1636521
  10. Donnez J., Donnez O., Dolmans M.M. The current place of medical therapy in uterine fibroid management. Best Pract Res Clin Obstet Gynaecol. 2018; 46: 57–65. doi: 10.1016/j.bpobgyn.2017.10.008
  11. Llewellyn O., Patel N.R., Mallon D. et al. Uterine Artery Embolisation for Women with Giant Versus Non-giant Uterine Fibroids: A Systematic Review and Meta-analysis. Cardiovasc Intervent Radiol. 2020; 43 (5): 684–93. doi: 10.1007/s00270-019-02359-7
  12. Xu F., Deng L., Zhang L. et al. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis. Int J Hyperthermia. 2021; 38 (2): 24–9. doi: 10.1080/02656736.2021.1933216
  13. Sandberg E.M., Tummers F.H.M.P., Cohen S.L. et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018; 109 (4): 698–707.e1. doi: 10.1016/j.fertnstert.2017.11.033
  14. Hussein A.M., Elbarmelgy R.A., Elbarmelgy R.M. et al. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder. Ultrasound Obstet Gynecol. 2022; 59 (4): 474–82. doi: 10.1002/uog.23732

补充文件

附件文件
动作
1. JATS XML
下载
2. Frequency of repeated interventions after focused ultrasound ablation, uterine artery embolization and myomectomy [12]

下载 (29KB)
索引源数据

版权所有 © Russkiy Vrach Publishing House, 2024